Stockreport

VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug [Yahoo! Finance]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF VKTX is developing the candidate in both oral and subcutaneous (SC) formulations for the potential treatment of various metabolic disorders, such as obesity. Viking Th [Read more]